What is a Clinical Trial Navigator?
A navigator is a person who is trained to help someone with cancer get the help they need. A navigator may be a peer (someone who also had or has cancer), a...
Read More PAST ARTICLES
2025
- How to Prepare for Your Visit With Your Healthcare Team
- Side Effects of MBC Treatments: Pain and Neuropathy
- Upcoming MBC Conferences in March
- What Are Radiopharmaceuticals and How Are They Used in MBC?
- FDA Approves Enhertu® for Hormone Receptor-Positive, HER2-Low or HER2-Ultralow MBC
- Dissecting Trial Information on ClinicalTrials.gov
- FDA Approves Datroway®
- Side Effects of MBC Treatments: Fatigue
- The Latest Triple-Positive MBC Research
- Mark Your 2025 Calendars!
- San Antonio Breast Cancer Symposium 2024
- Registries for People with MBC: The Results Are In!
2024
- What to Know About the Benefits of Sharing Your Medical Data
- Preparing for the 2024 San Antonio Breast Cancer Symposium (SABCS)
- Side Effects of MBC Treatments: Digestive System Side Effects
- Combining Radiation and Immunotherapy Treatment for MBC
- Can I Know if My MBC Treatment is Likely to Work?
- Different Types of Imaging Scans: Ultrasound Scans
- Invasive Lobular Breast Cancer (ILC) 2024
- New Efforts and Resources to Reduce the Financial Burden of Clinical Trial Participation
- Common Myths About Clinical Trial Participation: Just the Facts
- FDA Approves Itovebi
- How Does a Drug Get FDA Approved After Clinical Trials?
- European Society for Medical Oncology (ESMO) 2024
- Different Types of Imaging Scans: Bone Scans
- Newly Diagnosed with MBC: Advice from People with MBC
- The Latest in Treatments for MBC With Brain Metastases
- Highlighting MBC Awareness Day 2024
- Decoding the Different Types of MBC Treatment
- Different Types of Imaging Scans: PET/CT Scans
- Support with Toxic Positivity While Living With MBC
- American Society for Clinical Oncology (ASCO) 2024
- Different Types of Imaging Scans: MRI
- What You Need to Know About De Novo MBC Research
- Living Beyond Breast Cancer’s Thriving Together: 2024 Conference on Metastatic Breast Cancer
- Update on Oral SERDs and New Types of Hormone Therapies
- Update: New Biomarkers Can Now be Used to Select Treatment for MBC
- Tips for Vacationing or Traveling With MBC
- Turning “Cold” Tumors Into “Hot” Tumors: Researching How to Make Immunotherapy Work in More People With MBC
- American Association for Cancer Research (AACR) 2024
- Nutrition and Exercise When Living With MBC
- Decoding Clinical Trial Terms: Umbrella, Basket, and Tumor Agnostic Clinical Trials
- Managing Symptoms When MBC Spreads to the Bones
- Targeting the Androgen Receptor in MBC
- Miami Breast Cancer Conference 2024
- Prioritizing Your Mental Health When Living With MBC
- Decoding Clinical Trial Terms: Arms
- Dato-DXd Antibody-Drug Conjugate for Triple-Negative and Hormone Receptor-Positive MBC
- Trial Alerts: Now Available on Metastatic Trial Search!
- Managing Side Effects of ADCs
- Leptomeningeal Disease: How is it Different from Brain Metastasis and How is it Treated?
- What is “Drug Sequencing”?
- Decoding Clinical Trial Terms: Dose Escalation and Dose Expansion
- Our New Partner: CancerBuddy
- Experts Break Down Important MBC Research from SABCS 2023
- Discovering New Ways to Overcome Treatment Resistance in Triple-Negative MBC
- Mark Your 2024 Calendars!
- Decoding Clinical Trial Terms: Clinical Trial Design
- Using Social Media to Find Support While Living With MBC
- Now Available: MBC Clinical Trials Infographic
- San Antonio Breast Cancer Symposium 2023
2023
- What Are FES PET Scans and How Are They Used for Lobular Breast Cancer?
- What’s the Difference Between Targeted Therapy and Chemotherapy?
- Advanced Breast Cancer Seventh International Consensus Conference (ABC7)
- Invasive Lobular Breast Cancer Symposium 2023
- Preparing for San Antonio Breast Cancer Symposium (SABCS) 2023
- How Does a Clinical Trial Benefit Me?
- FDA Approves Truqap
- Our New Partner: GRASP
- Our New Partner: Unite for HER
- European Society for Medical Oncology 2023
- Biomarker Testing for MBC: What, When, and How?
- Why Are MBC Outcomes Worse for Black Women Than White Women?
- Leaving a Legacy and Hope: Tissue Donation After Death
- Metastatic Trial Search Tutorial Videos: Now Available!
- Metastatic Breast Cancer Research Conference 2023
- Highlighting MBC Awareness Day and the MBC Alliance
- Overcoming Resistance to CDK4/6 Inhibitors
- What are Placebos and How Are They Used in MBC Clinical Trials?
- Non-Treatment Trials: Surveys, Interviews, and Registries
- Researching Ways to Make MBC Treatment Easier to Tolerate
- Meet the Clinical Trial Team: The Institutional Review Board
- In Memory of Dr. Susan Love
- The Latest Research on Inflammatory Breast Cancer
- Meet the Clinical Trial Team: The Clinical Trial Sponsor
- American Association for Cancer Research (AACR) 2023
- American Society for Clinical Oncology (ASCO) 2023
- How is ER Low Used in Clinical Trials?
- Non-Treatment Trials: Predicting Response to Treatment and Decision Support
- Artificial Intelligence and MBC: Can AI Improve Detection and Treatment?
- Meet the Clinical Trial Team: The Principal Investigator
- Living Beyond Breast Cancer Conference 2023
- Non-Treatment Trials: Managing Side Effects
- Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
- The Latest Research on Lobular MBC
- What is the Microbiome and How Might it Affect MBC?
- Miami Breast Cancer Conference 2023
- Managing Other Health Conditions While Living with MBC
- Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
- Meet the Clinical Trial Team: The Clinical Trial Coordinator
- What are Clinical Practice Guidelines and How are They Developed?
- Who are Clinical Trial Research Team Members?
- Dating and Relationships While Living with MBC
- New Clinical Trials For Stage IV Breast Cancer
- What to Know About MBC Treatment-Related Heart Problems
- ASCO Experts Update Guidance for Sacituzumab Govitecan (Trodelvy®) for HR+, HER2- MBC
- What are Non-Treatment Trials and Why are They Important?
- Black Wo(Men) Speak Symposium 2022
- FDA Approves Orserdu and Expands Approval of Trodelvy®
- New ESR1 Biomarker Research Leads to FDA Approval for ER+, HER2- MBC with an ESR1 Mutation
- What is Stable Disease and How is it Monitored?
- Assembling a Healthcare Team That Hears and Respects You
- Clinical Trial Participation: The Patient’s Journey
- Metastatic Trial Search Featured in Clinical Trials Webinar
- Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
- I Found a Trial I’m Interested In. What’s Next?
- An Overview of Insurance and Clinical Trials
- New Announcement: Metastatic Trial Search is Mobile-Friendly!
2022
- Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
- The Latest Research on CDK 4/6 Inhibitors
- Patient-Reported Outcomes: Including the Patient Voice in MBC Research
- Clinical Trial Outcomes: What is Being Studied and How is it Measured?
- Which Foods, Supplements, and Drugs Should I Avoid During MBC Treatment?
- Why You Should Consider Repeat Biopsies
- Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
- Oncolytic Viruses: Using Viruses to Kill Cancer Cells
- Lobular Breast Cancer Metastasis: Highlighting the Researchers
- What is Measurable Disease?
- CURE®’s Educated Patient® Metastatic Breast Cancer Summit
- New Announcement: Introduction to MBC Clinical Trials Video
- What is it Like to Participate in a Clinical Trial?
- FDA Approves Enhertu® for HER2-Low MBC
- Why Knowing Your HER2 Status is Important
- Breast Cancer Lung Metastasis: Highlighting the Experts
- How To Find Clinical Trial Results
- How To Choose a Cancer Center
- All About Vaccines for MBC
- How Trial Participation is Becoming Easier: Managing Finances, Travel, and Other Considerations
- Breast Cancer Liver Metastasis: Highlighting the Experts
- What Are Crossover Trials and How Do They Work?
- Are You Hesitant to Participate in Trials Because of Data Privacy?
- Breast Cancer Bone Metastasis: Highlighting the Experts
- How Trial Participation Is Becoming Easier: Decentralization
- FDA Expands Approval for Enhertu®
- Triple-Negative Metastatic Breast Cancer: Beyond ER, PR, and HER2
- Breast Cancer Brain Metastasis: Highlighting the Experts
- Patient Advocate Foundation, Our Newest Partner!
- Why Attend a Medical Conference?
- All About Phase IV Clinical Trials
- Update on Immunotherapy for MBC: Immune Checkpoint Inhibitors
- Why Do Some People Have an Exceptional Response When Being Treated for MBC?
- All About Phase III Clinical Trials
- What is Complementary and Integrative Medicine?
- Update On Antibody-Drug Conjugates (ADCs) For MBC
- All About Phase II Clinical Trials
- Why Does The Same Drug Work Differently In Different People?
- When We Tri(al) Our New Partner!
- Virtual Conferences: How Do I Prepare?
- All About Phase I Clinical Trials
- Male MBC Treatment And Clinical Trials
- MBCBrainMets.org – Our New Partner!
- Bispecific Antibodies: An Emerging Class Of MBC Drugs
- MBC and NED
- “Standard of Care” for MBC
- Treatment for MBC While Pregnant
- MBC-Related News from SABCS
2021
- Advanced Breast Cancer Conference 2021
- Scan Anxiety
- Treatment Strategies for Triple-Positive MBC
- What do FGFR Genetic Mutations Mean for You and Your MBC?
- Understanding Informed Consent
- Cannabis Use For Managing Symptoms and Side Effects
- Metronomic Chemotherapy: Looking at A New Way to Receive Treatment
- Lobular Metastatic Breast Cancer
- Financial Toxicity: Managing Costs While Enrolled in a Clinical Trial
- What are Solid Tumor Trials and Why Are They Important?
- Prepare For SABCS 2021
- Inflammatory MBC Treatments
- Pink October/MBC Awareness Day
- Steps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials
- Metastatic Breast Cancer News from 2021 ESMO
- Theragnostics
- Spotlight on the Tigerlily Foundation & Breast Cancer Racial Disparities
- Health Insurance for MBC
- Atezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
- Metastatic Trial Search: New Features
- Metastatic Breast Cancer News from ASCO 2021
- FDA Fast Track
- Cell-Based Therapies: A Type of Immunotherapy for MBC
- Black Breast Cancer & BRCA1/2 Mutations
- Immunotherapy Resistance
- Modernizing Clinical Trials
- Update on Oral SERDs for Estrogen Receptor-Positive MBC
- MBC News from 2021 AACR Meeting
- Videos About Breast Cancer Clinical Trials
- Lymphodepletion in Cancer Immunotherapy
- Where You Can Find Current MBC Research
- Local Therapies for Liver Mets
- Y-90 Internal Radiation Therapy for Liver Mets
- St. Gallen International Breast Cancer Conference 2021
- Spotlight on New Partners
- 2021 Miami Breast Cancer Conference
- Just-in-Time Trials
- The Latest Research on Hormone Receptor-Positive (HR+) MBC
- Side Effects of Radiation Therapy for Brain Mets
- Other MBC Resources
- Metastatic Breast Cancer in the LGBTQI Communities
- Expanded Access
- 2021 Update on Metastatic Triple Negative Breast Cancer Treatment
- Screening for Breast Cancer Brain Metastases
- Participating in a Trial: Patient Voices
- FDA Approves MARGENZA
- Treating Breast Cancer Brain Mets
- Circulating Tumor Cell Testing
- What You Need to Know About Washout Periods
- Spotlight on MBC Podcasts
- What is Next-Generation Sequencing?
- Lines of Therapy: New Drugs May Change MBC Treatment
- What Are Lines of Therapy and What You Need to Know
- Warmest Wishes for 2021
2020
- When to Use Surgery & Radiation to the Breast
- Metastatic Trial Search: New & Improved
- Body Image and Metastatic Breast Cancer
- Giving the Right Dose of Drugs for MBC: The Patient-Centered Dosing Initiative and Project Optimus
- FDA Approves Keytruda®
- Creativity to Cope with MBC
- HER2-Low Expressing: A New Subcategory of HER2-Negative Breast Cancer?
- How to Prepare for a Virtual SABCS
- MBC, Advanced Breast Cancer & Locally Advanced Breast Cancer: What’s in a Name?
- Living with Metastatic Breast Cancer During October
- Different Types of Imaging Scans: How, When, and Why They are Used
- The Impact of MBC on Work and Career
- PD-L1 Biomarker for Immunotherapy
- Depression & Metastatic Breast Cancer
- LBBC’s Conference on Metastatic Breast Cancer
- Metastatic Breast Cancer at a Young Age
- How Participants are Divided into Treatment Groups in Clinical Trials
- Side Effects of MBC Treatments: Sexual Health Side Effects
- What is ER-Low Breast Cancer?
- Clinical Trials Are Not Only a Last Resort
- Spotlight on Metastatic Breast Cancer in Older People
- FDA Approves PHESGO
- HER2 Positive Metastatic Breast Cancer Research Update
- Peer Support for Metastatic Breast Cancer
- How to Find Metastatic Breast Cancer Clinical Trials
- Introduction to MBC Clinical Trials
- Telemedicine in Clinical Trials
- Recent FDA Approvals for Metastatic Breast Cancer
- What is a Patient Navigator?
- Find Trials That Are Right For You
- Managing Anxiety
- The Tumor Microenvironment
- Komen LA MBC Conference
- Black Women Facing Breast Cancer
- Do You Know Your Rights as a Cancer Patient?
- What is Your Tumor’s Mutation Burden?
- MBC in the Transgender Community
- Commonly Used Terms in Clinical Trials
- Exercise and Stage 4 Breast Cancer
- How To Get a Newly Approved Cancer Drug
- Triple-Negative Breast Cancer Update
- True or False?
- New Features on MTS
- Cancer & PTSD
- Big Data & Cancer Research
2019
- Warmest Wishes
- Tips for Reading Cancer News
- What Do Drug Names Mean?
- Getting Through the Holidays While Living with MBC
- Diagnosing & Treatment of Bone Metastases
- What is a Tumor Agnostic Therapy?
- True or False?
- What Are Inclusion and Exclusion Criteria?
- Dragon Boat Racing
- Genetic vs. Genomic Testing
- About MBC Awareness Day
- Treating Brain Metastases
- OS vs. PFS: What You Need to Know
- How to Ask Your Doctor About Clinical Trials
- More Men Needed in Breast Cancer Trials
- New FDA Approval: A PI3K Inhibitor
- True or False?
- New Guideline Includes Immunotherapy
- How to Get a Medical Interpreter
- Should You Get A Second Opinion?
- What is Oligometastatic Breast Cancer?
- Doctors & Patients on Clinical Trials
- Genomic Testing: What Makes Your Tumor Grow?
- MBC Facebook Groups
- Treatment Guidelines for Metastatic Breast Cancer
- Metastatic Breast Cancer Blogs
- Why the Phase of a Clinical Trial Matters
- Planning Ahead: Advance Care Plans
- First Immunotherapy Approved for MBC
- Video Portraits of MBC
- Coordinating Support for You and Your Family
- What to Know About Palliative Care for MBC
- The Latest Research on ctDNA and MBC
- From Down Under: Stories of MBC
- What Are Master Protocols?
- ¿Hablas Español?
- Learn From Home With a Webinar
- Get the Latest News on PARP Inhibitors
- Life with MBC: 10+ Years and Counting
- All about Basket and Umbrella Trials
- Consider a Retreat
- What is CAR-T Cell Immunotherapy?
- New Research Presented at San Antonio
- Patient and Advocate Perspectives on San Antonio
- Support for MBC Caregivers
- Managing Lymphedema
2018
- Reporting Side Effects in Cancer Clinical Trials
- Stories of De Novo Metastatic Breast Cancer
- Evidence-Based Information on Herbs and Supplements
- Your Tumor and Experience Could Lead to New Treatments
- Thriving at a Cancer Conference
- MBC Patients in The News
- Talking to Kids About MBC
- Biosimilar Drugs & Breast Cancer
- Immunotherapy & Metastatic Breast Cancer
- Living with Triple Negative MBC
- The Lack of Diversity in Clinical Trials
- Where to Find Financial Support
- Insights into Treatment Resistance
- Speaking Out on Inflammatory Breast Cancer
- Perspectives on Clinical Trials
- Living with MBC
- Managing Pain While Living with MBC
- Voices of Men with MBC
- Finding Support Groups
- CRISPR & Cancer
- Treating BRCA1/2 Metastatic Breast Cancer
- Metastatic Breast Cancer Advocacy
- Clinical Trials: Who Gets to Take Part?
- Share Links, Give Feedback, Tell Us Your Story
- Looking for a Helpline?
- Chemo, Second Opinions & Disability Insurance
SEARCH OUR SITE
for past articles or specific information.